Andere Sprachen Optimi Health Corp.

Aktien

A2QQEL

CA68405H1001

OPTI

Verzögert Canadian Securities Exchange Andere Börsenplätze 17:12:29 07.05.2024			% 5 Tage	% 1. Jan.
0.34 ^CAD	0.00%		+6.25%	+38.78%

23.04.	Optimi Health und das Applied Genomics Centre der Kwantlen Polytechnic University kooperieren, um die Pilzwissenschaft und -forschung voranzutreiben	CI
15.04.	Optimi Health Corp. schließt die Eigenproduktion des pharmazeutischen Wirkstoffs MDMA ab	CI

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

Optimi Health and Kwantlen Polytechnic University Applied Genomics Centre Partner to Advance Mushroom Science and Research	23.04.
Optimi Health and Kwantlen Polytechnic University Applied Genomics Centre Partner to Advance Mushroom Science and Research	23.04.
Optimi Health Achieves Milestone: Completes In-House Production of MDMA Active Pharmaceutical Ingredient (API)	15.04.
Optimi Health Achieves Milestone: Completes In-House Production of MDMA Active Pharmaceutical Ingredient (API)	15.04.
Optimi Health Corp. Completes In-House Production of MDMA Active Pharmaceutical Ingredient	15.04.
Optimi Health Signs Psilocybin Supply Agreement With New Zealand-Based Mātai Medical Research Institute	09.04.
Optimi Health Corp. Signs Psilocybin Supply Agreement with Matai Medical Research Institute	09.04.
Early Warning Press Release in Accordance with National Instrument 62-103	04.04.
Optimi Health Receives Finished Product Test Results and Certificate Of Analysis for GMP Natural Psilocybin Extract	02.04.
Optimi Health Corp. Receives Finished Product Test Results and Certificate of Analysis for GMP Natural Psilocybin Extract	02.04.
Optimi Health Confirms Presenting Sponsorship at the 4th Annual Psychedelic Therapeutics and Drug Development Conference	28.03.
Optimi Health Confirms Presenting Sponsorship at the 4th Annual Psychedelic Therapeutics and Drug Development Conference	28.03.
Optimi Health to Supply MDMA for Psychedelic Research at Tel Aviv University	26.03.
Optimi Health to Supply MDMA for Psychedelic Research at Tel Aviv University	26.03.
Optimi Health to Supply MDMA for Psychedelic Research at Tel Aviv University	26.03.
Optimi Health Corp. Reports Earnings Results for the First Quarter Ended December 31, 2023	01.03.
Optimi Announces Closing of First Tranche of Non-Brokered Private Placement	28.02.
492,000 Warrants of Optimi Health Corp. are subject to a Lock-Up Agreement Ending on 26-FEB-2024.	26.02.
606,000 Options of Optimi Health Corp. are subject to a Lock-Up Agreement Ending on 26-FEB-2024.	26.02.
3,048,000 Common Share of Optimi Health Corp. are subject to a Lock-Up Agreement Ending on 26-FEB-2024.	26.02.

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen Optimi Health Corp.

Aktien

A2QQEL

CA68405H1001

OPTI

Andere Sprachen

Filter